Company newsroom Organon share Link copied Health & Healthcare Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Today, Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, embarks on the next phase of programming for “Her Plan is Her Power,” to improve access and outcomes related to unplanned pregnancy in the U.S. Feb 20, 2024 7:30 AM ET Read the full story All Releases Health & Healthcare Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET Health & Healthcare Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World Nov 14, 2022 7:30 AM ET Health & Healthcare Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET Health & Healthcare Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World Nov 14, 2022 7:30 AM ET Sign Up for Our Newsletters Get the latest news straight to your inbox, curated everyday. Email Address 3BL Newsletter (Daily) CSRwire Newsletter (Daily) The 3BL network Readers who read Organon also read Browse all newsrooms → Cayman Islands Ministry of Education and Training Healthcare Services 0 stories View newsroom → MilliporeSigma Healthcare Services 355 stories Latest 10 Years, 10 Stories: From Curiosity to Career Oct 30, 2026 View newsroom → Republic of Green Healthcare Services 0 stories View newsroom → Quest Diagnostics Healthcare Services 344 stories Latest Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year Feb 24, 2025 View newsroom →
Health & Healthcare Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Today, Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, embarks on the next phase of programming for “Her Plan is Her Power,” to improve access and outcomes related to unplanned pregnancy in the U.S. Feb 20, 2024 7:30 AM ET Read the full story
Health & Healthcare Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET
Health & Healthcare Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World Nov 14, 2022 7:30 AM ET
Health & Healthcare Organon Launches U.S. Grant Programs and Listening Tour as Part of “Her Plan Is Her Power,” Reaching High-Need Communities To Help Reduce Unplanned Pregnancies Feb 20, 2024 7:30 AM ET
Health & Healthcare Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World Nov 14, 2022 7:30 AM ET
MilliporeSigma Healthcare Services 355 stories Latest 10 Years, 10 Stories: From Curiosity to Career Oct 30, 2026 View newsroom →
Quest Diagnostics Healthcare Services 344 stories Latest Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year Feb 24, 2025 View newsroom →